3Westphal SA,Sarosi GA.Diabetic ditoacidosis associated with pulmonary.Clin Infect Dis,1994,18(6):974-978
4Segado-Soriano A,Lopez-Gonnzalez-Cobos C,Granda-Martin MJ,et al.Infectious pathology in diabetic patients cared for in an emergency department.Am Med Intern,1999,16(1):3-7
5Colquhoun AJ,Nicholson KG,Botha JH,et al.Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes.Epidemiol Infect,1997,119(3):335-341
6Christ-Crain M,Morgenthaler NG,Struck J,et al.Mid-regional pro-ADM as a prognostic marker in sepsis:an observational study[J].Crit Care,2005,9(6):816 -824.
7Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101:1644-1665.
8Emanuel P,Lauralyn McIntyre,David C,et al.Early and innovative inter vention for severe sepsis and septic shock:taking advantage of a window of opportunity[J].CMAJ,2005,10 (25):173-179.
9Karimova A,Pinsky DJ.The endothelial response to oxygen deprivation:biology and clinical implications[J].Intensive Care Med,2001,27:19 -31.
10Reinhart K,Kuhn HJ,Hartog C,et al.Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill[J].Intensive Care Med,2004,30:1572-1578.
3Pierrakos C,Vincent JL. Sepsis biomark-ers: a review [J]. Crit Care,2010,14:R15.
4Pemer A,Haase N,Guttormsen AB,et al.Hydroxyethyl starch 130/0. 42 versusRinger's aretate in severe sepsis[J]. N EnglJ Med,2012,367:124-134.
5Micek S T,Welch E C,Khan J,et al. Em-piric combination antibiotic therapy is asso-ciated with improved outcome against sepsisclue to Gram-negative bacteria: a retrospec-tive analysis [J]. Antimicrob AgentsChemother, 2010,54( 5); 1742-1748.
